These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12147144)

  • 1. A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with Type 1 diabetes.
    Howells L; Wilson AC; Skinner TC; Newton R; Morris AD; Greene SA
    Diabet Med; 2002 Aug; 19(8):643-8. PubMed ID: 12147144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes.
    Franklin VL; Waller A; Pagliari C; Greene SA
    Diabet Med; 2006 Dec; 23(12):1332-8. PubMed ID: 17116184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes control with reciprocal peer support versus nurse care management: a randomized trial.
    Heisler M; Vijan S; Makki F; Piette JD
    Ann Intern Med; 2010 Oct; 153(8):507-15. PubMed ID: 20956707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal observational study of insulin therapy and glycaemic control in Scottish children with Type 1 diabetes: DIABAUD 3.
    Scottish Study Group for the Care of the Young with Diabetes
    Diabet Med; 2006 Nov; 23(11):1216-21. PubMed ID: 17054598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial.
    Franciosi M; Lucisano G; Pellegrini F; Cantarello A; Consoli A; Cucco L; Ghidelli R; Sartore G; Sciangula L; Nicolucci A;
    Diabet Med; 2011 Jul; 28(7):789-96. PubMed ID: 21342243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial.
    Weinger K; Beverly EA; Lee Y; Sitnokov L; Ganda OP; Caballero AE
    Arch Intern Med; 2011 Dec; 171(22):1990-9. PubMed ID: 21986346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446).
    Farmer AJ; Gibson OJ; Dudley C; Bryden K; Hayton PM; Tarassenko L; Neil A
    Diabetes Care; 2005 Nov; 28(11):2697-702. PubMed ID: 16249542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care.
    Goudswaard AN; Stolk RP; Zuithoff NP; de Valk HW; Rutten GE
    Diabet Med; 2004 May; 21(5):491-6. PubMed ID: 15089797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
    Sherry N; Hagopian W; Ludvigsson J; Jain SM; Wahlen J; Ferry RJ; Bode B; Aronoff S; Holland C; Carlin D; King KL; Wilder RL; Pillemer S; Bonvini E; Johnson S; Stein KE; Koenig S; Herold KC; Daifotis AG;
    Lancet; 2011 Aug; 378(9790):487-97. PubMed ID: 21719095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
    Lund SS; Tarnow L; Astrup AS; Hovind P; Jacobsen PK; Alibegovic AC; Parving I; Pietraszek L; Frandsen M; Rossing P; Parving HH; Vaag AA
    PLoS One; 2008; 3(10):e3363. PubMed ID: 18852875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study).
    Charpentier G; Benhamou PY; Dardari D; Clergeot A; Franc S; Schaepelynck-Belicar P; Catargi B; Melki V; Chaillous L; Farret A; Bosson JL; Penfornis A;
    Diabetes Care; 2011 Mar; 34(3):533-9. PubMed ID: 21266648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.
    Ratner RE; Dickey R; Fineman M; Maggs DG; Shen L; Strobel SA; Weyer C; Kolterman OG
    Diabet Med; 2004 Nov; 21(11):1204-12. PubMed ID: 15498087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
    Kanazawa Y; Igarashi Y; Komiya K; Sakurai Y; Shimizu T; Fujitani Y; Tanaka Y; Watada H; Kawamori R; Hirose T
    Endocr J; 2007 Dec; 54(6):975-83. PubMed ID: 18000343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S; Hansen TW; Andersen S; Rossing P
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c).
    Cohen HW; Shmukler C; Ullman R; Rivera CM; Walker EA
    Diabet Med; 2010 Feb; 27(2):210-6. PubMed ID: 20546266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.